FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes the novel derivatives of cycloalkanoindole and azaindole, mixture of their isomers and separate isomers of the general formula (I) 
, their pharmaceutically acceptable salts where R1 and R2 in common with binding their double bond mean phenyl or pyridyl ring or ring of the formula (A) 
where R8 means hydrogen atom, C1-C4-alkyl; R1, R4 in common with their binding double bond mean phenyl ring or four-eight-membered cycloalkene residue being indicated for R1/R2 and R3/R4 rings are unsubstituted or substituted with 1-3 similar or different substituents taken among the group including CF3, C1-C6-alkoxy-group, C1-C6-alkoxycarbonyl-group, C1-C6-alkyl and the latter can be substituted with hydroxy-group; D is hydrogen atom, C4-C12-cycloalkyl, C1-C12-alkyl; E is group CO- or CS; L is O, S, -NR9; R9 is hydrogen atom, C1-C6-alkyl possibly substituted with phenyl, hydroxy-group; R5 is phenyl, pyridyl, thienyl that can be substituted; R6 is hydrogen atom, carboxy-group, C1-C5-alkoxycarbonyl-group, C1-C6-alkyl that can be substituted with hydroxy-group, -O-CO-R15; R15 is possibly substituted phenyl, C1-C22-alkyl, C2-C22-alkenyl; R7 is hydrogen atom; R6 and R7 in common mean group of the formula = O. Invention describes also intermediate compounds and pharmaceutical composition inhibiting the release of lipoproteins associated with apolipoprotein B-100. EFFECT: new compounds indicated above, valuable pharmacological properties. 5 cl, 35 tbl, 192 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF HETEROCYCLE-SUBSTITUTED PHENYLCYCLOHEXANE CARBOXYLIC ACID, MIXTURE OF THEIR ISOMERS OR SEPARATE ISOMERS AND THEIR SALTS | 1994 |
|
RU2125990C1 |
| DERIVATIVES OF HETEROCYCLE-SUBSTITUTED PHENYLCYCLOHEXANECARBOXYLIC ACID, MIXTURE OR THEIR ISOMERS OR INDIVIDUAL ISOMERS AND THEIR SALTS | 1994 |
|
RU2119480C1 |
| DERIVATIVES OF BENZOFURANYLALKANE CARBOXYLIC ACID OR A MIXTURE OF THEIR ISOMERS, OR SEPARATE ISOMERS, OR THEIR SALTS | 1994 |
|
RU2125564C1 |
| DERIVATIVES OF CYCLOALKANOPYRIDINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND INTERMEDIATE COMPOUNDS | 1997 |
|
RU2194698C2 |
| 2,8-DISUBSTITUTED QUINAZOLINONE DERIVATIVES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS BASED ON THE LATTER AFFECTING BLOOD LEVELS OF GUANOSINE AND ADENOSINE MONOPHOSPHATES | 1996 |
|
RU2158733C2 |
| N-(3-BENZOFURANYL)UREA DERIVATIVES, MIXTURE OF THEIR ISOMERS OR INDIVIDUAL ISOMERS AND THEIR SALTS | 1996 |
|
RU2162845C2 |
| DIHYDROPYRIDINE DERIVATIVES, MIXTURE OF THEIR ISOMERS, INDIVIDUAL ISOMERS OR THEIR PHYSIOLOGICALLY TOLERANTABLE SALTS, METHODS OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS AND METHOD OF THEIR SYNTHESIS | 1992 |
|
RU2081872C1 |
| DERIVATIVES OF CYCLOHEXADIENE, MIXTURE OF THEIR ISOMERS OR SEPARATE ISOMERS AND THEIR SALTS AND PHARMACEUTICAL COMPOSITION WITH SELECTIVE MODULATING EFFECT ON CALCIUM-DEPENDENT POTASSIUM CHANNELS OF HIGH CONDUCTIVITY | 1995 |
|
RU2155748C2 |
| DERIVATIVES OF PHENYLCYCLOHEXYLCARBOXYLIC ACID AMIDE, MIXTURE OF THEIR OR SEPARATE ISOMERS AND THEIR SALTS, PHARMACEUTICAL COMPOSITION WITH ANTIARTERIOSCLEROTIC AND ANTIRESTENOSIS ACTIVITY | 1996 |
|
RU2158261C2 |
| 4H-PYRAN DERIVATIVES, MIXTURE OF ISOMERS THEREOF, INDIVIDUAL ISOMERS AND SALTS THEREOF | 1996 |
|
RU2164915C2 |
